VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ACMR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ACMRACM Research, Inc.
$126.89$8.4B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksACMRBalance Sheet

ACM Research, Inc. (ACMR) Balance Sheet

11Y historyFree accessUpdated daily

The company maintains a healthy financial position with a conservative debt-to-equity ratio of 0.16 and a robust cash balance of $894.1 million as of 2026Q1.

ACMR Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15
Total Current Assets2.62B2.44B1.48B1.18B963.81M952.93M260.66M198.4M96.03M62.91M40.35M27.95M
Cash & Short-Term Investments1.29B1.17B444.1M283.93M338.65M592.05M100M58.26M27.12M17.68M10.12M4.4M
Cash Only894.13M765.96M407.44M182.09M247.95M562.55M71.77M58.26M27.12M17.68M10.12M4.4M
Short-Term Investments392.9M402.12M36.65M101.84M90.7M29.5M28.24M00000
Accounts Receivable580.97M552.9M428.9M325.68M212.55M125.61M66.12M33.69M28.16M29.25M17.79M13.29M
Days Sales Outstanding203.24223.91200.16213.14199.53176.51154.09114.38137.68292.48237.22155.49
Inventory738M702.63M597.98M545.39M393.17M218.12M88.64M44.8M38.76M15.39M11.67M9.15M
Days Inventory Outstanding471.24511.65558.84707.15699.3549.45371.77287.51352.01291.3303.24195.39
Other Current Assets13.35M2.5M3.87M1.08M500K519K059.6M046K53K7K
Total Non-Current Assets446.55M435.5M372.34M314.8M271.69M99.25M80.6M19.31M7.02M4.98M4.12M4.2M
Property, Plant & Equipment341.08M332.75M283.31M208.87M85.36M61.2M12.49M7.51M3.71M2.34M2.26M1.77M
Fixed Asset Turnover2.96x2.71x2.76x2.67x4.55x4.24x12.54x14.33x20.13x15.60x12.10x17.63x
Goodwill000000000000
Intangible Assets2.72M2.85M3.46M2.54M9.95M10.92M10.2M344K274K106K17K1K
Long-Term Investments254.78M66.03M50.34M68.7M119.42M12.69M6.34M5.93M1.36M1.24M-1.84M-2.43M
Other Non-Current Assets4.05M4.48M20.45M14.42M50.27M1.26M40.5M192K40K01.84M2.43M
Total Assets3.07B2.87B1.86B1.49B1.24B1.05B341.26M217.7M103.05M67.89M44.47M32.15M
Asset Turnover0.36x0.31x0.42x0.37x0.31x0.25x0.46x0.49x0.72x0.54x0.62x0.97x
Asset Growth %190.06%54.77%24.47%20.67%17.42%208.32%56.75%111.27%51.78%52.68%38.31%-
Total Current Liabilities745.68M745.71M641.23M500.66M396.21M205.94M102.91M53.5M46.14M21.82M17.07M20.57M
Accounts Payable240.66M247.5M139.29M153.22M101.73M93.45M35.6M13.26M16.67M7.42M4.67M2.09M
Days Payables Outstanding142.74180.23130.18198.66180.95235.41149.3385.12151.41140.45121.2644.74
Short-Term Debt112.08M113.91M77.29M38.12M58.33M12M27.74M13.75M9.45M5.11M4.77M9.69M
Deferred Revenue (Current)839.14M205.2M252.49M185.06M157.95M56M19.23M9.13M8.42M143K215K4.63M
Other Current Liabilities128.61M178.12M0100.26M61.15M015.82M01.95M7.46M3.49M439K
Current Ratio3.51x3.27x2.31x2.35x2.43x4.63x2.53x3.71x2.08x2.88x2.36x1.36x
Quick Ratio2.52x2.33x1.38x1.26x1.44x3.57x1.67x2.87x1.24x2.18x1.68x0.91x
Cash Conversion Cycle531.73555.33628.83721.63717.88490.55376.53316.77338.28443.34419.2306.15
Total Non-Current Liabilities236.75M195.96M118.58M64.09M27.11M34.58M30.18M66.88M4.58M6.22M24.91M16.06M
Long-Term Debt220.86M184M105.53M53.95M18.69M22.96M17.98M00000
Capital Lease Obligations20.57M5.07M3.84M4.26M1.11M1.87M2.88M2.53M0000
Deferred Tax Liabilities000001.3M1.29M00000
Other Non-Current Liabilities11.77M6.9M1.17M1.3M7.32M684K8.03M63.1M4.58M6.22M24.91M16.06M
Total Liabilities982.43M941.68M759.82M564.75M423.33M240.51M133.09M120.38M50.72M28.03M41.98M36.63M
Total Debt337.06M302.98M188.78M99.1M79.5M39.14M50.01M17.64M9.45M5.11M4.77M9.69M
Net Debt-557.07M-462.99M-218.66M-82.99M-168.45M-523.41M-21.75M-40.62M-17.68M-12.57M-5.35M5.29M
Debt / Equity0.16x0.16x0.17x0.11x0.10x0.05x0.24x0.18x0.18x0.13x1.92x-
Debt / EBITDA2.43x2.41x1.17x0.95x1.23x0.95x2.22x0.95x1.37x5.26x1.30x1.93x
Net Debt / EBITDA-4.02x-3.68x-1.36x-0.80x-2.62x-12.75x-0.96x-2.19x-2.57x-12.95x-1.45x1.05x
Interest Coverage20.41x20.44x41.06x44.35x41.70x50.59x20.65x23.88x12.99x2.53x19.28x39.86x
Total Equity2.08B1.93B1.1B926.16M812.17M811.66M208.17M97.32M52.32M39.86M2.48M-4.48M
Equity Growth %251.83%76.16%18.33%14.04%0.06%289.9%113.9%86%31.28%1503.9%155.48%-
Book Value per Share29.8628.6816.5514.2812.4312.423.281.700.970.880.10-0.56
Total Shareholders' Equity1.58B1.46B904.63M767.39M674.86M676.2M141.15M97.32M52.32M39.86M-2.43M-8.24M
Common Stock7K7K7K7K6K6K2K2K1K1K2K280K
Retained Earnings367.74M350.43M260M156.83M94.43M63.73M34.29M15.51M-3.39M-9.96M-9.64M-10.68M
Treasury Stock00000000000-2.24M
Accumulated OCI18.98M-1.58M-32.86M-19.29M-23.66M17.42M4.86M-1.68M-857K122K-413K-84K
Minority Interest501.96M466.15M191.28M158.77M137.31M135.46M67.02M0004.92M3.76M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowDeteriorating
Top Statement Risk

Geopolitical and liquidity concentration

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Expansion Outpacing Equity Growth

According to recent balance sheet filings, ACMR has aggressively expanded its total assets from $1.5 billion in 2023Q4 to $3.1 billion by 2026Q1, a trend that suggests a rapid scaling of operations despite the inherent volatility in its underlying project-based revenue recognition cycles.

The doubling of the asset base over ten quarters indicates a significant commitment to infrastructure and inventory to support market share gains. However, investors should monitor whether this asset intensity will eventually yield commensurate returns or if it merely reflects a buildup of potentially illiquid inventory in the Chinese market.

Cash Position Masks Working Capital

Based on reported financial statements, ACMR maintains a robust cash balance of $894.1 million as of 2026Q1, yet the current ratio of 3.51 appears somewhat inflated by significant accounts receivable and inventory levels that may not be easily converted into cash during a sector downturn.

While the headline liquidity appears strong, the divergence between cash on hand and operating cash flow suggests that the company's liquidity is heavily tied to the timing of customer acceptances. This reliance on long-cycle project payments warrants further investigation into the quality of the current asset base.

Conservative Leverage Amidst Growth Phase

As indicated by the company's financial disclosures, ACMR maintains a conservative debt-to-equity ratio of 0.16% as of 2026Q1, suggesting that management has successfully funded its rapid expansion through equity and operational cash rather than relying on significant external debt financing.

This low leverage profile provides a necessary buffer against the geopolitical and regulatory risks inherent in the company's China-centric business model. The lack of significant debt obligations implies that the company is not currently facing immediate refinancing pressure, though it remains vulnerable to equity market sentiment.

Geographic Concentration Distorts Asset Quality

Based on an analysis of the company's reported figures, the concentration of assets within mainland China, including a large portion of the $894.1 million cash balance, may present a hidden risk regarding the actual accessibility and fungibility of these funds for global corporate purposes.

The dual-listing structure and the geographic concentration of operations suggest that the balance sheet may be less flexible than the headline numbers imply. Investors should consider that regulatory or geopolitical friction could potentially restrict the movement of capital or the realization of asset values currently held within the Chinese subsidiary.

ACMR — Frequently Asked Questions

Quick answers to the most common questions about buying ACMR stock.

What are the total assets of ACM Research, Inc. (ACMR)?

As of 2025, ACM Research, Inc. (ACMR) had total assets of $2.87B including $2.44B in current assets.

How much debt does ACM Research, Inc. (ACMR) have?

ACM Research, Inc. (ACMR) carries total debt of $303.0M, offset by $1.17B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of ACM Research, Inc.?

ACM Research, Inc. (ACMR) has total shareholders' equity (book value) of $1.46B ($28.68 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is ACM Research, Inc.'s current ratio and liquidity?

ACM Research, Inc. (ACMR) reported a current ratio of 3.27x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.